Granules India profit and loss

Latest FY26

Revenue: ₹5,366cr+19.7% on FY25
EBITDA: ₹1,185cr+25.4% on FY25
Net profit: ₹595cr+18.6% on FY25
EPS: ₹24.47+18.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	5,632	5,366	4,482	4,506	4,512	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	6.3	20.3	12.9	4.4	13.8
	5,639	5,386	4,495	4,511	4,526
	2,167	2,100	1,725	2,208	2,353
	−209	−224	0.8	−187	−45.4
	940	888	660	598	472
	112	114	103	106	55.9
	307	296	226	207	184
	1,456	1,416	1,151	1,031	819
	4,774	4,591	3,865	3,964	3,839
	1,277	1,185	945	856	914
	970	889	720	649	729
Profit
	865	795	629	547	687
	15.9	−10.0	30.8	0.0	0.0
	881	785	660	547	687
	223	196	183	165	177
	−4.1	−6.2	−24.2	−23.3	−6.6
	219	190	159	142	171
	662	595	502	405	517
	662	595	502	405	517
	154	143	27.0	20.5	56.9
	817	738	529	426	574
	—	—	502	426	517
Per share
	₹27.06	₹24.47	₹20.69	₹16.73	₹21.05
	₹26.92	₹24.46	₹20.68	₹16.72	₹21.00
Other comprehensive income — detail
	154	143	27.0	—	—
	—	10.3	2.1	−0.6	1.0
	—	2.1	0.5	—	—
	—	—	—	−0.1	0.2
	142	123	26.3	23.9	54.4
	−4.2	−12.5	0.8	—	—
	—	—	—	3.0	−1.8
	—	—	529	—	574
Per share — as-filed variants
	₹27.06	₹24.47	₹20.69	₹16.73	₹21.05
	₹26.92	₹24.46	₹20.68	₹16.72	₹21.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	3,674	3,490	2,756	2,485	2,205
	65.2%	65.0%	61.5%	55.1%	48.9%
Adjusted (ex-exceptional items) — derived
	865	795	629	547	687
	15.9	−10.0	30.8	0.0	0.0
	650	603	478	405	517
	₹26.57	₹24.78	₹19.73	₹16.73	₹21.05

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GRANULES₹840.45

Granules India Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersAUROPHARMA IPCALAB AARTIDRUGS ERIS INDGN EMCURE JUBLPHARMA CONCORDBIOMcap ₹20,826 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	4,511.9	4,506.4	4,481.6	5,365.6	5,632.3
Other Income	13.8	4.4	12.9	20.3	6.3
Total Income	4,525.7	4,510.8	4,494.5	5,386.0	5,638.6
Expenses
+ Cost of Materials Consumed	2,352.7	2,208.2	1,724.9	2,099.8	2,167.1
+ Changes in Inventories	-45.4	-187.0	0.8	-224.1	-208.7
+ Employee Benefit Expense	472.2	597.9	659.8	888.4	940.2
+ Finance Costs	55.9	105.8	103.2	114.4	111.7
+ Depreciation & Amortisation	184.5	207.3	225.5	296.1	306.9
+ Other Expenses	818.6	1,031.3	1,150.9	1,416.4	1,456.4
Total Expenses	3,838.5	3,963.5	3,865.1	4,591.0	4,773.6
EBITDA	913.8	856.0	945.2	1,185.1	1,277.3
EBIT	729.3	648.6	719.7	889.0	970.4
Profit
PBT before Exceptional Items	687.2	547.2	629.4	795.0	864.9
+ Exceptional Items	0.0	0.0	30.8	-10.0	15.9
Pretax Income	687.2	547.2	660.2	785.0	880.9
+ Current Tax	177.2	165.2	182.8	196.1	222.6
+ Deferred Tax	-6.6	-23.3	-24.2	-6.2	-4.1
Tax Expense	170.6	141.9	158.7	190.0	218.5
Net Income	516.6	405.3	501.5	595.0	662.3
+ Net Income — Continuing Ops	516.6	405.3	501.5	595.0	662.3
+ Other Comprehensive Income	56.9	20.5	27.0	143.3	154.3
Total Comprehensive Income	573.5	425.8	528.5	738.3	816.7
Net Income to Common	516.6	425.8	501.5	—	—
Per Share
Basic EPS	21.05	16.73	20.69	24.47	27.06
Diluted EPS	21.00	16.72	20.68	24.46	26.92
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	27.0	143.3	154.3
+ Items NOT to be Reclassified to P&L	1.0	-0.6	2.1	10.3	—
+ Tax on Items NOT to be Reclassified	—	—	0.5	2.1	—
+ Tax on Items NOT to be Reclassified — alt tag	0.2	-0.1	—	—	—
+ Items to be Reclassified to P&L	54.4	23.9	26.3	122.6	141.9
+ Tax on Items to be Reclassified	—	—	0.8	-12.5	-4.2
+ Tax on Items to be Reclassified — alt tag	-1.8	3.0	—	—	—
Comprehensive Income — Owners of Parent	573.5	—	528.5	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	21.05	16.73	20.69	24.47	27.06
Diluted EPS — Continuing Operations	21.00	16.72	20.68	24.46	26.92
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	2,204.6	2,485.1	2,755.9	3,489.9	3,673.9
Gross Margin %	48.86	55.15	61.49	65.04	65.23
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	687.2	547.2	629.4	795.0	864.9
− Exceptional Items (reconciliation)	0.0	0.0	30.8	-10.0	15.9
Net Income Adj (tax-effected)	516.6	405.3	478.2	602.6	650.4
EPS Adj	21.05	16.73	19.73	24.78	26.57
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	24.2	24.2	24.3	24.8	24.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.